Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: A case-series study

Arthritis Research and Therapy

Volumn 13, Issue 3, 2011, Pages

  Laskari, Katerina ^a   Tzioufas, Athanasios G ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LEFLUNOMIDE; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEROID;

ABSCESS; ADOLESCENT; ADULT; AMERICAN COLLEGE OF RHEUMATOLOGY 20 SCORE; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; GASTROENTERITIS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INFECTION; INFLUENZA A (H1N1); INJECTION SITE HYPERSENSITIVITY; JUVENILE RHEUMATOID ARTHRITIS; MALE; RELAPSE; SCORING SYSTEM; SIDE EFFECT; SYMPTOM; TRACHEOBRONCHITIS; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URTICARIA; VISUAL ANALOG SCALE; ADULT ONSET STILL DISEASE; AGED; COMPARATIVE STUDY; DRUG COMBINATION; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; METHOTREXATE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STEROIDS; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958819509     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3366     Document Type: Article

References (24)

1. Pouchot J, Sampalis JS, Beaudet F, Carette S, Décary F, Salusinsky-Sternbach M, Hill RO, Gutkowski A, Harth M, Myhal D, Senécal JL, Yeadon C, Esdaile JM. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991, 70:118-136.
2. Aarntzen EH, van Riel PL, Barrera P. Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?. Ann Rheum Dis 2005, 64:1523-1524. 10.1136/ard.2005.042945, 1755234, 16014669.
3. Fujii T, Akizuki M, Kameda H, Matsumura M, Hirakata M, Yoshida T, Shinozawa T, Mimori T. Methotrexate treatment in patients with adult onset Still's disease-retrospective study of 13 Japanese cases. Ann Rheum Dis 1997, 56:144-148. 10.1136/ard.56.2.144, 1752327, 9068291.
4. Fautrel B, Borget C, Rozenberg S, Meyer O, Le Loët X, Masson C, Koeger AC, Kahn MF, Bourgeois P. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 1999, 26:373-378.
5. Fautrel B, Sibilia J, Mariette X, Combe B, . Club Rhumatismes et Inflammation Tumour necrosis factor a blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 2005, 64:262-266. 10.1136/ard.2004.024026, 1755371, 15184196, Club Rhumatismes et Inflammation.
6. Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gravallese EM, Weinblatt ME. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 2002, 46:1171-1176. 10.1002/art.10231, 12115220.
7. Caramaschi P, Biasi D, Carletto A, Bambara LM. A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol 2002, 20:113.
8. Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001, 19:329-332.
9. Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 2004, 23:45-49. 10.1007/s10067-003-0775-5, 14749983.
10. Kraetsch HG, Antoni C, Kalden JR, Manger B. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 2001, 60:55-57. 10.1136/ard.60.1.55, 1753360, 11114283.
11. Dinarello CA. Blocking IL-1 in systemic inflammation. JEM 2005, 201:1355-1359.
12. Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB, . 990145 Study Group A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 2004, 63:1062-1068. 10.1136/ard.2003.016014, 1755108, 15082469, 990145 Study Group.
13. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005, 52:1794-1803. 10.1002/art.21061, 15934079.
14. Vasques Godinho FM, Parreira Santos MJ, Canas da Silva J. Refractory adult onset Still's disease successfully treated with anakinra. Ann Rheum Dis 2005, 64:647-648. 10.1136/ard.2004.026617, 1755446, 15374853.
15. Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, Günaydin I, Kanz L. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 2007, 37:189-197. 10.1016/j.semarthrit.2007.04.002, 17583775.
16. Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis SN. Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 2007, 66:842-843. 10.1136/ard.2006.066381, 1954650, 17513574.
17. Maier J, Birkenfeld G, Pfirstinger J, Schölmerich J, Fleck M, Brühl H. Effective treatment of steroid refractory adult-onset Still's disease with anakinra. J Rheumatol 2008, 35:939-941.
18. Lequerré T, Quartier P, Rosellini D, Alaoui F, De Bandt M, Mejjad O, Kone-Paut I, Michel M, Dernis E, Khellaf M, Limal N, Job-Deslandre C, Fautrel B, Le Loët X, Sibilia J, , . Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP), Club Rhumatismes et Inflammation (CRI) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 2008, 67:302-308. Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP), Club Rhumatismes et Inflammation (CRI).
19. Naumann L, Feist E, Natusch A, Langen S, Krause A, Buttgereit F, Burmester GR. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease. Ann Rheum Dis 2010, 69:466-467. 10.1136/ard.2009.108068, 20107032.
20. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, Akizuki M. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992, 19:424-430.
21. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995, 38:727-735. 10.1002/art.1780380602, 7779114.
22. Guignard S, Dien G, Dougados M. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug Anakinra: a case report. Clin Exp Rheum 2007, 25:758-759.
23. Gattorno M, Piccini A, Lasigliè D, Tassi S, Brisca G, Carta S, Delfino L, Ferlito F, Pelagatti MA, Caroli F, Buoncompagni A, Viola S, Loy A, Sironi M, Vecchi A, Ravelli A, Martini A, Rubartelli A. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2008, 58:1505-1515. 10.1002/art.23437, 18438814.
24. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. JEM 2005, 201:1479-1486.